Yi Sheng

1.4k total citations
28 papers, 787 citations indexed

About

Yi Sheng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yi Sheng has authored 28 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Oncology and 5 papers in Immunology. Recurrent topics in Yi Sheng's work include Cancer-related Molecular Pathways (10 papers), Ubiquitin and proteasome pathways (9 papers) and Cytomegalovirus and herpesvirus research (3 papers). Yi Sheng is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Ubiquitin and proteasome pathways (9 papers) and Cytomegalovirus and herpesvirus research (3 papers). Yi Sheng collaborates with scholars based in Canada, China and United Kingdom. Yi Sheng's co-authors include Feroz Sarkari, Marina Kirkitadze, Lori Frappier, C.H. Arrowsmith, V. Saridakis, Olga Egorova, Shan Wang, Rahima Khatun, Brian Raught and Anthony La Delfa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Yi Sheng

26 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Sheng Canada 16 549 253 122 101 64 28 787
Juan I. Barrasa Spain 10 404 0.7× 185 0.7× 71 0.6× 95 0.9× 76 1.2× 13 658
Linhui Zhai China 19 681 1.2× 155 0.6× 113 0.9× 71 0.7× 112 1.8× 48 941
Claire Gondeau France 20 473 0.9× 121 0.5× 261 2.1× 60 0.6× 58 0.9× 32 915
Chunfang Hu China 14 421 0.8× 225 0.9× 65 0.5× 91 0.9× 158 2.5× 36 752
Boyka Markova Germany 18 946 1.7× 195 0.8× 60 0.5× 297 2.9× 79 1.2× 38 1.4k
Zhen Tong United Kingdom 8 453 0.8× 206 0.8× 38 0.3× 46 0.5× 49 0.8× 10 714
Ana Mitrović Slovenia 15 340 0.6× 216 0.9× 58 0.5× 83 0.8× 186 2.9× 42 837
Pengyu Liu China 16 402 0.7× 114 0.5× 79 0.6× 121 1.2× 158 2.5× 48 703
Qing Yu China 15 456 0.8× 123 0.5× 107 0.9× 68 0.7× 97 1.5× 30 641
Katelyn O’Neill United States 11 560 1.0× 137 0.5× 113 0.9× 162 1.6× 109 1.7× 15 813

Countries citing papers authored by Yi Sheng

Since Specialization
Citations

This map shows the geographic impact of Yi Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Sheng more than expected).

Fields of papers citing papers by Yi Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Sheng. The network helps show where Yi Sheng may publish in the future.

Co-authorship network of co-authors of Yi Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Sheng. A scholar is included among the top collaborators of Yi Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Sheng. Yi Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yeqiao, et al.. (2025). OLIVE provides rapid visualization and analysis of chromatin tracing experiments. Cell Reports Methods. 5(11). 101209–101209. 1 indexed citations
2.
Sheng, Yi, et al.. (2025). ID-insensitive deepfake detection model based on multi-attention mechanism. Scientific Reports. 15(1). 11168–11168.
3.
Wen, Yating, et al.. (2025). Endoplasmic reticulum: the target of chlamydial manipulation. Archives of Microbiology. 207(9). 219–219.
4.
Zhao, Yong, et al.. (2021). Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2. Interdisciplinary Sciences Computational Life Sciences. 14(1). 64–79. 7 indexed citations
5.
Sheng, Yi, et al.. (2021). Process Analytical Technologies – Advances in bioprocess integration and future perspectives. Journal of Pharmaceutical and Biomedical Analysis. 207. 114379–114379. 93 indexed citations
6.
Miri, Saba, Seyyed Mohammadreza Davoodi, Satinder Kaur Brar, et al.. (2020). Psychrozymes as novel tools to biodegrade p-xylene and potential use for contaminated groundwater in the cold climate. Bioresource Technology. 321. 124464–124464. 18 indexed citations
7.
Khatun, Rahima, Howard N. Hunter, Yi Sheng, Bruce Carpick, & Marina Kirkitadze. (2018). 27Al and 31P NMR spectroscopy method development to quantify aluminum phosphate in adjuvanted vaccine formulations. Journal of Pharmaceutical and Biomedical Analysis. 159. 166–172. 10 indexed citations
8.
Dominguez‐Brauer, Carmen, Rahima Khatun, Andrew Elia, et al.. (2017). E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling. Proceedings of the National Academy of Sciences. 114(7). E1148–E1157. 44 indexed citations
9.
Wheaton, Keith, Feroz Sarkari, Olga Egorova, et al.. (2017). UbE2E1/UBCH6 Is a Critical in Vivo E2 for the PRC1-catalyzed Ubiquitination of H2A at Lys-119. Journal of Biological Chemistry. 292(7). 2893–2902. 22 indexed citations
10.
Egorova, Olga, et al.. (2016). Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7. Journal of Biological Chemistry. 291(12). 6281–6291. 37 indexed citations
11.
Khatun, Rahima, et al.. (2016). Nuclear Magnetic Resonance (NMR) Study for the Detection and Quantitation of Cholesterol in HSV529 Therapeutic Vaccine Candidate. Computational and Structural Biotechnology Journal. 15. 14–20. 17 indexed citations
12.
Dzneladze, Irakli, et al.. (2015). Functional analyses of polymorphic variants of human terminal deoxynucleotidyl transferase. Genes and Immunity. 16(6). 388–398. 3 indexed citations
13.
Egorova, Olga & Yi Sheng. (2014). A site-directed mutagenesis study of the MdmX RING domain. Biochemical and Biophysical Research Communications. 447(4). 696–701. 7 indexed citations
14.
Bohgaki, Miyuki, Anne Hakem, Toshiyuki Bohgaki, et al.. (2013). The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover. Cell Death and Differentiation. 20(6). 812–822. 41 indexed citations
15.
Sarkari, Feroz, Keith Wheaton, Anthony La Delfa, et al.. (2013). Ubiquitin-specific Protease 7 Is a Regulator of Ubiquitin-conjugating Enzyme UbE2E1. Journal of Biological Chemistry. 288(23). 16975–16985. 39 indexed citations
16.
Sheng, Yi, Jenny H. Hong, Ryan Doherty, et al.. (2012). A Human Ubiquitin Conjugating Enzyme (E2)-HECT E3 Ligase Structure-function Screen. Molecular & Cellular Proteomics. 11(8). 329–341. 96 indexed citations
17.
Espinosa, Alexander, Janosch Hennig, Aurélie Ambrosi, et al.. (2011). Anti-Ro52 Autoantibodies from Patients with Sjögren's Syndrome Inhibit the Ro52 E3 Ligase Activity by Blocking the E3/E2 Interface. Journal of Biological Chemistry. 286(42). 36478–36491. 66 indexed citations
18.
Sarkari, Feroz, Anthony La Delfa, C.H. Arrowsmith, et al.. (2010). Further Insight into Substrate Recognition by USP7: Structural and Biochemical Analysis of the HdmX and Hdm2 Interactions with USP7. Journal of Molecular Biology. 402(5). 825–837. 46 indexed citations
19.
Sarkari, Feroz, et al.. (2009). EBNA1-Mediated Recruitment of a Histone H2B Deubiquitylating Complex to the Epstein-Barr Virus Latent Origin of DNA Replication. PLoS Pathogens. 5(10). e1000624–e1000624. 93 indexed citations
20.
Li, Qihan, Lichun Wang, Chenghong Dong, et al.. (2005). The interaction of the SARS coronavirus non-structural protein 10 with the cellular oxido-reductase system causes an extensive cytopathic effect. Journal of Clinical Virology. 34(2). 133–139. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026